National health plan

Recent Articles

RELATED ARTICLES

  1. The Chinese drug developer put a rocket booster under its share price after enlisting a Japanese rival as a new equity partner and unveiling plans for a U.S. listing.
    Ascentage Pharma soars on deal with cancer drug competitor
    6855.HK
  2. Hutchmed scores U.S. success with cancer drug, but profits still dip
    HCM.US 0013.HK
  3. Everest Medicines eyes mRNA tumor vaccines as drug valuations rebound
    1952.HK
  4. Inaugural operating profit fails to lift 111 Inc.
    YI.US
  5. Novel drugs lift Sino Biopharm earnings, easing price-cap pain
    1177.HK
  6. CSPC Pharma taps R&D superstar in quest for new breakout drugs
    1093.HK
Discover hidden China stock gems in our weekly newsletter

Follow us

Facebook Twitter Linkedin Weixin Weibo Youtube

Subscribe to Our Free eNewsletter

Subscribe

Check out our content with some of our syndication partners

factiva